Thursday, March 04, 2021 9:24:42 AM
By:
1. get your emotions out of this PRONTO
2. re-affirm you are invested TO MAKE MONEY, not lose it!
3. formulate an EXIT STRATEGY, based on your cost basis plus
the amount per share you want (profit you would like) to gain.
4. set your SELL price as good til cancelled
5. Evaluate how much you would be willing to LOSE triggering an early exit. This is the hardest part. Making the decision of "I will sell all or half my position if pps drops to 'x' or x % of my purchase cost. Normally I do not set a stop loss because if there is a lot of volatility in the stock or the market, the stop loss could be triggered on a "bad day".
6. DISCIPLINE, DISCIPLINE, DISCIPLINE!! Stick to your plan, you will sleep at night if you do! Some times you will come out like a champ, and some times you will be a chump....but you won't second-guess your investment thesis if you plan it out carefully based on the most information you can muster to support that thesis. Don't listen to message board pundits on price, that will be determined by the market who is more interested in INTRINSIC VALUE of sales, revenues, products, company, shares outstanding, etc. etc. etc.
7. Say your prayers each night, drink your KL in moderation!
Best of luck to you- Chxal
Recent SRNE News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM
- Shanghai Escugen Biotechnology Co., Ltd., a partner of Levena Biopharma, a Sorrento Company, releases positive results from a first-in-human study of ESG401, a TROP2 Antibody Drug Conjugate in patients with locally advanced/metastatic solid tumors at the A • GlobeNewswire Inc. • 06/05/2023 01:00:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM